| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.81 | $2.27 | $2.62 | $2.34 | $2.54 | $1.65 | $1.79 | $1.27 |
| EPS (Diluted) | $2.79 | $2.26 | $2.59 | $2.32 | $2.53 | $1.64 | $1.74 | $1.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $7.9B | $6.6B | $6.0B | $4.7B | $4.2B | $2.3B | $2.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $7.3B | $7.1B | $5.9B | $5.4B | $4.3B | $3.8B | $2.0B | $1.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.8B | $0.6B | $0.6B | $0.4B | $0.4B | $0.3B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.5B | $-0.7B | $-0.7B | $-0.5B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $0.3B | $0.5B | $0.7B | $0.5B | $0.5B | $0.2B | $0.1B |